Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "EU ORPHAN DRUG|Positive" in comments (approximate match)

Showing 491 - 500 of 713 results

First page
Previous page
Next page
Next page

VOLRUBIGENE RALAPARVOVEC

8WI5RJ8D9V

Status:

Investigational

Source:

NCT03223194: Phase 1 Interventional Terminated Crigler-Najjar Syndrome

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03223194

Class:

STRUCTURALLY DIVERSE

Oxalobacter formigenes HC-1

W0KQL6X5JI

Status:

Investigational

Source:

NCT01037231: Phase 2/Phase 3 Interventional Completed Primary Hyperoxaluria

(2009)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01037231

Class:

STRUCTURALLY DIVERSE

Tabelecleucel

G3NJ7M8N4H

Status:

Investigational

Source:

NCT03394365: Phase 3 Interventional Recruiting Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03394365

Class:

STRUCTURALLY DIVERSE

PELAREOREP

S9J80L3D1U

Status:

Investigational

Source:

NCT04215146: Phase 2 Interventional Active, not recruiting Breast Cancer Metastatic

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04215146

Class:

STRUCTURALLY DIVERSE

HUMAN STAPHYLOCOCCUS AUREUS IMMUNE GLOBULIN

SX5Y4A7UBI

Status:

Investigational

Source:

NCT00066989: Phase 2 Interventional Completed Staphylococcal Infections

(2003)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00066989

Class:

STRUCTURALLY DIVERSE

IMM-101

IZT740JY57

Status:

Investigational

Source:

NCT04442048: Phase 3 Interventional Active, not recruiting Cancer

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04442048

Class:

STRUCTURALLY DIVERSE

BOS TAURUS BILE IMMUNOMODULATOR

E5SF1Z7U1S

Status:

Investigational

Source:

NCT00040092: Phase 3 Interventional Completed Pancreatic Cancer

(2002)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00040092

Class:

STRUCTURALLY DIVERSE

BOVINE TYPE I COLLAGEN (SKIN)

0127KU7397

Status:

Designated

Source:

EU-Orphan Drug:EU/3/08/607

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/0127KU7397

Class:

STRUCTURALLY DIVERSE

LACTOBACILLUS ACIDOPHILUS

1PRR1V42V5

Status:

US Previously Marketed

Source:

Lactobacillus acidophilus

(1921)

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

First marketed in 1921

Source:

Lactobacillus acidophilus

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

SAW PALMETTO

J7WWH9M8QS

Status:

US Previously Marketed

Source:

Tincture of Saw Palmetto and Santal N.F.

(1921)

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

First marketed in 1921

Source:

Tincture of Saw Palmetto and Santal N.F.

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

VOLRUBIGENE RALAPARVOVEC

Structurally Diverse

Oxalobacter formigenes HC-1

Structurally Diverse

Structurally Diverse

PELAREOREP

Structurally Diverse

HUMAN STAPHYLOCOCCUS AUREUS IMMUNE GLOBULIN

Structurally Diverse

IMM-101

Structurally Diverse

BOS TAURUS BILE IMMUNOMODULATOR

Structurally Diverse

BOVINE TYPE I COLLAGEN (SKIN)

Structurally Diverse

LACTOBACILLUS ACIDOPHILUS

Structurally Diverse

SAW PALMETTO

Showing 491 - 500 of 713 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1